AI Tool Predicts Bowel Cancer Drug Response for Patients

Researchers at London's Institute of Cancer Research and RCSI University develop an AI tool, PhenMap, to predict how advanced bowel cancer patients will respond to a new NHS drug. This innovation aims to prevent thousands from receiving ineffective treatments, enhancing patient care and outcomes.

Read the full story at The Guardian AU→